May 2019
A Roadmap for Results: Supporting Countries to Plan for the ECHO Trial Results
May 7, 7:00 am - 8:00 am EDT The global health community eagerly awaits results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which are expected in July. The ECHO trial is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the progestogen-only injectable depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant, and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of…
Find out more »June 2019
Women Deliver 2019
The world's largest conference on the health, rights, and wellbeing of girls and women.
Find out more »A Roadmap for Results: Understanding the ECHO Trial Findings (Webinar)
Results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study will be released at SA AIDS in Durban, South Africa, on Thursday, June 13th. The ECHO team is committed to sharing these results globally – particularly with stakeholders in both the HIV and family planning communities. This webinar will provide background on the ECHO trial, present the results, and outline next steps. To ensure a coordinated and strategic response to the results at the country level, it is…
Find out more »ECHO Study Results Announcement
Save the date — June 13, 2019 — for this late-breaker session at the 9th SA AIDS Conference, which will include presentations on the primary analysis of data from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study. The announcement will occur at 2:00pm South Africa time (8:00am ET). This pivotal and long-awaited randomised clinical trial, conducted at 12 sites in Eswatini, Kenya, South Africa and Zambia, compared the relative risk of HIV acquisition among 7,829 women who used…
Find out more »